Nature · 2016
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK.
Show affiliations
- Kleinstiver BP — Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
- Pattanayak V — Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
- Prew MS — Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
- Tsai SQ — Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
- Nguyen NT — Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
- Zheng Z — Department of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
- Joung JK — Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
20 read2 want to readRigor 2.6Novelty 3.3Impact 2.6Reprod. 3.4
Most-cited papers citing this
- Front Neurol · 2025 · cited by 12
- Plant Environ Interact · 2026 · cited by 8
- Nature · 2026 · cited by 7
- Drug Deliv · 2026 · cited by 6
- Pharmaceutics · 2026 · cited by 6
Log in to like, log, and share thoughts on this paper.
Discussion
Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.